close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

IVT Lab Week Event Combining Method Validation, Laboratory Compliance and Stability Testing

ISELIN, N.J.--(BUSINESS WIRE)--Jul 10, 2007 - The Institute of Validation Technology, a division of Advanstar Communications, has announced its Lab Week Event - a three-day conference providing a comprehensive guide to method validation, laboratory compliance, and stability testing. Lab Week (www.labweekevent.com) will take place in San Diego, CA, from October 2-5, 2007 and will feature more than 40 presentations from industry leaders, including Patrick J. Bell of Wyeth Pharmaceuticals; Ludwig Huber, Ph.D., of Agilent Technologies; and Barry Scheer, Ph.D., of Bristol-Myers Squibb.

The conference will also feature two FDA presentations: FDA's Final OOS Guidance, presented by Paul Haynie, Compliance Officer, Division of Manufacturing and Product Quality, FDA; and Regulatory Considerations for Stability Testing, presented by Barry Rothman, Senior Compliance Officer, Division of Manufacturing and Product Quality, FDA.

QC Manager of Marketed Biotech Products, Michael Noelchen, attended IVT's Laboratory Compliance conference in London last year, and stated "I feel very confident in the advanced training I received."

"The comprehensive nature of the IVT conference propelled me to volunteer as a future speaker at IVT events, and I am happy to say I am one of the featured speakers at the Lab Week Event in San Diego this October," he said.

The Lab Week Event schedule investigates the industry's most critical issues, with Laboratory Compliance topics including Risk-Based Validation, Designing GMP Training Programs, Managing Risk in the Verification of Standard Methods, Current FDA 483s and Warning Letter Trends.

Method Validation topics covered include FDA/USP Guidances, Analytical Method Transfer, Test Method Validation, LC Method Development with Validation in Mind.

Stability Testing subjects include Risk Management, LIMS, Chamber Temperature and RH Mapping, OOS Investigations for Stability Samples, and Regulatory Requirements.

For more information on this conference or to register, please visit www.labweekevent.com, or contact Advanstar's Customer Service Department at 888-524-9922 (U.S. only) or 218-740-7028.

About the Institute of Validation Technology

The Institute of Validation Technology (www.ivthome.com) is dedicated to expanding the global knowledge base for validation and compliance professionals in FDA-regulated industries. Through educational publications, timely conferences, and other informational products, The Institute of Validation Technology (IVT) stands alone in its quest to continually advance validation technology and practice, as well as help assure compliance with FDA regulations.

Contact

Advanstar Communications
Anne Marie Ricciardi, 732-346-3073
Fax: 732-596-0003
aricciardi@advanstar.com

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...